Associations between eNOS polymorphisms and susceptibility to Behcet's disease: A meta-analysis

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 10, 2012, Pages 1266-1271

  Lee, Y H ^a   Song, G G ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADDITIVE MODEL; ALLELE CONTRAST; ARTICLE; ASIA; BEHCET DISEASE; DOMINANT MODEL; ETHNICITY; GENE FREQUENCY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RECESSIVE MODEL; RISK FACTOR; TURKEY (REPUBLIC);

ALLELES; BEHCET SYNDROME; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 84866242633     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04280.x     Document Type: Article

References (26)

1. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-1080.
2. Sakane T, Takeno M, Suzuki N, et al. Behcet's disease. N Engl J Med 1999; 341: 1284-1291.
3. Moncada S, Palmer RM, Higgs EA,. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
4. Hattori R, Sase K, Eizawa H, et al. Structure and function of nitric oxide synthases. Int J Cardiol 1994; 47: S71-S75.
5. Orem A, Vanizor B, Cimsit G, et al. Decreased nitric oxide production in patients with Behcet's disease. Dermatology 1999; 198: 33-36.
6. Fowkes FG, Lee AJ, Hau CM, et al. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 2000; 150: 179-185.
7. Tesauro M, Thompson WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832-2835.
8. Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190-193.
9. Dursun A, Durakbasi-Dursun HG, Dursun R, et al. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behcet's disease with or without ocular involvement. Inflamm Res 2009; 58: 401-405.
10. Ben Dhifallah I, Houman H, Khanfir M, et al. Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunisian population. Hum Immunol 2008; 69: 661-665.
11. Nakao K, Isashiki Y, Sonoda S, et al. Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease. Arch Ophthalmol 2007; 125: 246-251.
12. Oksel F, Keser G, Ozmen M, et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behcet's disease. Clin Exp Rheumatol 2006; 24: S79-S82.
13. Kara N, Senturk N, Gunes SO, et al. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphism (glu298asp) with Behcet's disease in the Turkish population. Arch Dermatol Res 2006; 297: 468-471.
14. Karasneh JA, Hajeer AH, Silman A, et al. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behcet's disease. Rheumatology (Oxford) 2005; 44: 614-617.
15. Kim JU, Chang HK, Lee SS, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 2003; 62: 1083-1087.
16. Salvarani C, Boiardi L, Casali B, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease. J Rheumatol 2002; 29: 535-540.
17. Lee YH, Rho YH, Choi SJ, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 2007; 46: 49-56.
18. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
19. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
20. Egger M, Smith GD, Phillips AN,. Meta-analysis: principles and procedures. BMJ 1997; 315: 1533-1537.
21. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
22. Lakhanpal S, Tani K, Lie JT, et al. Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985; 16: 790-795.
23. Hong SN, Park JC, Yoon NS, et al. Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement. Korean J Intern Med 2008; 23: 87-93.
24. Wang XL, Sim AS, Badenhop RF, et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-45.
25. Ichihara S, Yamada Y, Fujimura T, et al. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81: 83-86.
26. Chambers JC, Haskard DO, Kooner JS,. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001; 37: 517-520.